background image

Paid Clinical Trials Wichita

Discover 146 paid clinical trials in Wichita, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder

for
Major Depressive Disorder
Location: 24 recruiting locations
Sponsor: Syndeio Biosciences, Inc

Sex: All

Age: 18 - 64

Code: NCT06547489

Phase2, Recruiting
Active & Responsive

SELUTION 4 De Novo Small Vessel IDE Trial

for
Coronary Artery Disease
Location: 36 recruiting locations
Sponsor: M.A. Med Alliance S.A.

Sex: All

Age: 18+

Code: NCT05946629

Recruiting
Active & Responsive

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

for
Lung Cancer Diagnosis
Location: 36 recruiting locations
Sponsor: Freenome Holdings Inc.

Sex: All

Age: 50+

Code: NCT06122077

Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

for
Moderately to Severely Active Ulcerative Colitis
Location: 49 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06588855

Phase3, Recruiting
Active & Responsive

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

for
Hypertension, Hypertension, Systolic, Hypertension, Essential
Location: 57 recruiting locations
Sponsor: Orchestra BioMed, Inc

Sex: All

Age: 18+

Code: NCT06059638

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

for
Polycystic Ovary Syndrome, Infertility, Female
Location: 18 recruiting locations
Sponsor: May Health

Sex: Female

Age: 18 - 40

Code: NCT06206746

Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: 31 recruiting locations
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting
Active & Responsive

TECTONIC CAD IVL IDE Study

for
Coronary Artery Calcification, Coronary Artery Disease,
Location: 31 recruiting locations
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT06885177

Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: 79 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819878

Phase3, Recruiting
New

A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: 16 recruiting locations
Sponsor: Verdiva Bio Dev Limited

Sex: All

Age: 18 - 70+

Code: NCT07281937

Phase2, Recruiting